Display options
Cite
Sadri K, Momenypoor S, Dabbagh Kakhki VR, et al. Nano Liposomes Labeled with (99m)Tc-HMPAO, a Novel Agent for Blood Pool Imaging. Iran J Pharm Res. 2015;14(4):981-8
Sadri, K., Momenypoor, S., Dabbagh Kakhki, V. R., Sadeghi, R., Aryana, K., Johari Daha, F., Zakavi, S. R., & Jaafari, M. R. (2015). Nano Liposomes Labeled with (99m)Tc-HMPAO, a Novel Agent for Blood Pool Imaging. Iranian journal of pharmaceutical research : IJPR, 14(4), 981-8.
Sadri, Kayvan, et al. "Nano Liposomes Labeled with (99m)Tc-HMPAO, a Novel Agent for Blood Pool Imaging." Iranian journal of pharmaceutical research : IJPR vol. 14,4 (2015): 981-8.
Sadri K, Momenypoor S, Dabbagh Kakhki VR, Sadeghi R, Aryana K, Johari Daha F, Zakavi SR, Jaafari MR. Nano Liposomes Labeled with (99m)Tc-HMPAO, a Novel Agent for Blood Pool Imaging. Iran J Pharm Res. 2015;14(4):981-8. PMID: 26664365; PMCID: PMC4673926.
Copy Download .nbib Format: NLM
Share it on

Iran J Pharm Res. 2015;14(4):981-8.

Nano Liposomes Labeled with (99m)Tc-HMPAO, a Novel Agent for Blood Pool Imaging.

Iranian journal of pharmaceutical research : IJPR

Kayvan Sadri, Salimeh Momenypoor, Vahid Reza Dabbagh Kakhki, Ramin Sadeghi, Kamran Aryana, Fariba Johari Daha, Seyed Rasoul Zakavi, Mahmoud Reza Jaafari

Affiliations

  1. Nuclear Medicine Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
  2. Biotechcology Research Center, Nanotechnology Research Center, School of Pharmacy, MUMS, Mashhad, Iran.
  3. Nuclear Science and Technology Research Institute, Tehran, Iran.

PMID: 26664365 PMCID: PMC4673926

Abstract

In-vitro labeling of RBC with (99m)Tc is an intricate procedure and there is always a need for an alternate blood pool imaging agent. The aim of this study was to prepare an effective nano sized liposome (NLs) similar to human RBC for blood pool scintigraphy. This study formulates PEG-NLs and non-PEG-NLs using film method plus high pressure homogenization technique. Biodistribution studies were performed on BALB/C mice 1, 4 and 24 h after tail vein injection of labeled NLs with (99m)Tc hexamethylpropylene-amine-oxime ((99m)Tc-HMPAO). Planar images were acquired using a 256 × 256 matrix following(99m) Tc-HMPAO-NLs injection into ear vein of rabbits 1, 2 and 24 h later. SPECT images were obtained 15 minutes after the injection (64 slices, 30 second/projection). The mean diameter, zeta potential and polydispersity index (PDI) of the PEG-NLs and the NLs were (80.88 ± 0.594 nm, -12.5 ± 0.56 mv, 0.158 ± 0.025) and (94.14 ± 0.114 nm, -35.5 ± 0.67 mv and 0.198 ± 0.007), respectively. (99m)Tc-HMPAO-PEG-NLs showed a significant circulation tracer activity (7.74 ± 1.63%ID/g at 1 h and 4.9 ± 0.77 %ID/g at 4 h), with low liver accumulation (12.07 ± 3.66 %ID/g at 1 h and 14.85 ± 1.3 %ID/g at 4 h). Heart to liver, spleen and background ROIs (region of interests) for (99m) Tc-HMPAO-PEG-NLs were 1.25, 4 and 4.28 respectively at 2 h which changed to 1.06, 1.75 and 2.51 respectively at 24 h. The (99m)Tc-HMPAO-PEG-NLs with a prolonged blood circulation time could be an excellent RBC alternative for scintigraphy and gastrointestinal bleeding.

Keywords: 99mTc-HMPAO; Blood Pool Imaging; Nano liposomes; RBC; SPECT

References

  1. J Nucl Med. 1996 Aug;37(8):1374-9 - PubMed
  2. J Pharmacol Exp Ther. 1999 Feb;288(2):665-70 - PubMed
  3. Int J Rad Appl Instrum B. 1992 Jul;19(5):539-47 - PubMed
  4. Arch Biochem Biophys. 1998 Sep 15;357(2):185-94 - PubMed
  5. Semin Nucl Med. 1982 Apr;12 (2):184-218 - PubMed
  6. J Am Chem Soc. 2002 Apr 24;124(16):4180-1 - PubMed
  7. Cancer Biother Radiopharm. 2005 Dec;20(6):620-8 - PubMed
  8. Int J Pharm. 2003 Mar 6;253(1-2):121-32 - PubMed
  9. Int J Pharm. 2013 Dec 31;458(2):324-33 - PubMed
  10. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2009 Jan-Feb;1(1):69-83 - PubMed
  11. Chem Phys Lipids. 1993 Sep;64(1-3):275-85 - PubMed
  12. Nat Rev Drug Discov. 2005 Feb;4(2):145-60 - PubMed
  13. Int J Pharm. 2011 Apr 15;408(1-2):163-72 - PubMed
  14. Eur J Nucl Med. 1995 Jan;22(1):61-7 - PubMed

Publication Types